Michelle LaSpaluto
Director of Finance/CFO at CHIMERIX, INC.
Net worth: 98 900 $ as of 2024-04-29
Michelle LaSpaluto active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CHIMERIX, INC. | Director of Finance/CFO | 2023-11-30 | - |
| Investor Relations Contact | 2018-12-31 | 2023-11-30 | |
| Public Communications Contact | - | 2023-11-30 |
Career history of Michelle LaSpaluto
Former positions of Michelle LaSpaluto
| Companies | Position | Start | End |
|---|---|---|---|
AlphaVax, Inc.
 AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Comptroller/Controller/Auditor | 2000-04-30 | 2011-05-31 |
Training of Michelle LaSpaluto
| Michigan State University | Undergraduate Degree |
| East Carolina University | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Michelle LaSpaluto
- Experience
